In this study, we also identified the PT area as the place of crosstalk between macrophages expressing EBI3 and p35 mRNA and the induction of IL-35+ cells in the TU region of NSCLC patients who might be relevant for future combined immunotherapy strategies. The gene discussed is EBI3; the disease is non-small cell lung carcinoma.